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Nanoscience is well recognized as a revolutionary 
step in various field of science and a logical field of study 
for researchers in the coming years as it is, the study 
of fundamental principles of molecules and structures 
between one nanometer (one billionth of a meter) and 
100 nanometers in size [1–4]. The biological application 
of nano-particles is a rapidly developing area of nano-
technology that raises new possibilities in the diagnosis 
and treatment of various diseases [5–10]. 
Nanotechnologies and nanostructures are becoming 
an option in human medical application, including ima-
ging or the delivery of therapeutic drugs to cells, tissues 
and organs [11–14]. Unique nanoparticles peculiari-
ties such as high surface energy, stable biomolecules 
absorption, physicochemical peculiarities changes 
under the influence of physical fields, their small sizes 
comparable to biomolecules, magnetic peculiarities 
availability, biocompatibility open new perspectives 
of nanopreparations using in therapy of various diseases 
including cancer. Today many nanomedicine studies are 
devoted to the development of principally new medica-
tions using magnetic nanoparticles as a carrier in antitu-
mor drugs to tissues- and target-cells delivery systems. 
Many types of nanocomposites used in experiments 
are made of iron particles [9, 12, 13]. However it is not 
known how ferromagnetic nanoparticles will influence 
аntitumor drugs activity in vivo taking into account their 
size and concentration. 
Therefore the aim of our study was to investigate 
the influence of ferromagnetic nanoparticles on anti-
tumor effect of doxorubicin in experiment. Moreover 
as active centers of many complexes of mitochondria 
respiratory chain contain iron [15], we have investi-
gated the influence of ferromagnetic nanoparticles 
on tumor cell oxygen consumption and mitochondria 
oxidative phosphorylation. 
MATERIALS AND METHODS
Synthesis and characterization of the ferromag-
netic nanoparticles. We used magnetite Fe3O4 synthe-
sized by the method of electron-beam evaporation, and 
Fe3O4 and NaCl deposition in vacuum. The stabilization 
of ferromagnetic was carried out by adding 1% polydex-
trane-70 and phosphatidylcholine during dispersion. 
Size of stabilized particles was determined using laser 
correlation spectrometry. Average ferromagnetic nano-
particles (FM) diameter was 20–40 nm (Fig. 1). 
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Fig. 1. Distribution of iron oxide particles by size
Determination of the iron content in solution. 
Iron concentrations (mg/ml) were measured by ato-
mic-absorption spectroscopy [16].
Groups of animals. The study was carried out 
on the mice-hybrids (C57Bl/6xDBA/2; body weight = 
20 g) with intraperitoneally (i/p) transplantated Ehrlich 
ascitic carcinoma (1.8 x 106 cells/mouse). Single i/p in-
jection of doxorubicin (Dox, “EBEWE”, Austria), stabi-
lized ferromagnetic nanoparticles or their combination 
was performed 7 days after tumor transplantation. Mice 
were divided in 5 groups: 1 — control (i/p 0.3 ml of sa-
line); 2 — doxorubicin administration (i/p; 3 mg/kg body 
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weight); 3 — ferromagnetic nanoparticles administra-
tion (i/p; 3 mg Fe/kg body weight); 4 — FM administra-
tion (i/p; 3 mg/kg body weight) and Dox administration 
(i/p; 3 mg/kg body weight) an hour later; 5 — Dox 
administration and FM administration an hour later 
(Table 1). The cytotoxic effect of agents was studied 
24, 48 and 72 h after administration. The morphology 
and cell cycle of tumor cells were examined. 
Table 1. Groups of animals
Group 
Number Name Description
1 Control i/p 0.3 ml of saline
2 Dox Doxorubicin administration (i/p 3 mg/kg body)
3 FM Ferromagnetic nanoparticles administration 
(i/p 3 mg Fe/kg body)
4 FM + Dox Ferromagnetic nanoparticles administration 
(i/p 3 mg Fe/kg body) and doxorubicin administra-
tion (i/p 3 mg/kg body) 1 h later
5 Dox + FM Doxorubicin administration (i/p 3 mg/kg body) 
and ferromagnetic nanoparticles administration 
(i/p 3 mg Fe/kg body) and 1 h later
The determination of cytotoxic effect. The 
mean number of dead cells (using trypan blue stain) 
was the index of cytotoxic effect. 
The cell cycle study. The cell cycle was stu-
died by means of flow cytometer (“Coulter Epics XL”, 
Beckman Coulter) with using of propidium iodide. The 
results were processed in ModFit program. The cell 
cycle of tumor cells taken from intraperitoneal cavity 
after i/p injections to mice Dox, FM or their combina-
tions was studied. Moreover the cell cycle of intact 
Ehrlich ascitic carcinoma cells was studied after these 
cells incubation in vitro with Dox and FM. In this case, 
the FM concentration was constant (in terms of Fe) 
at 100 μM. But Dox was added in three different con-
centrations: 1 μM, 10 μM and 100 μM. 100 μM Dox 
approximately corresponds to a therapeutic dose 
of 3 mg/kg in vivo conditions.
The determination of oxygen consumption rate. 
In the first experiments the Ehrlich carcinoma cells were 
incubated (Medium 199, Sigma, USA; 1.5 h; 26 °C) 
in presence of 0.73, 1.45, 7.25 and 14.5 μg Fe/ml. After 
incubation the oxygen consumption rate was deter-
mined. 
In the second experiments mitochondria were iso-
lated from tumor cells. The isolation medium contained 
0.25 M sucrose, 0.01 M Tris-HCl, 0.001 M EDTA and 
0.5% bovine or human albumin, pH 7.4. Homogenate 
was centrifugated at 600 g for 3 min, then at 1000 g for 
7 min without stop. The obtained supernatant was cen-
trifugated for 10 min at 14 000 g. After that supernatant 
was removed and the fraction of mitochondria was 
resuspended in 0.35 ml of pre-cooled isolation me-
dium. The mitochondria suspensions were incubated 
in presence of 1.45 μg Fe/ml and 7.25 μg Fe/ml (1.5 h; 
3 °C). Then 0.02 ml of every mitochondria sample was 
put into polarographic cell 1 ml in volume containing 
the incubation medium (0.15 M sucrose, 0.05 M KCl, 
0.01 M KH2PO4, 0.003 M MgCl2, 0.005 M Tris-HCl, 
0.005 M succinate, 0.0002 M EDTA, pH 7.4). In 3 min 
after the beginning of registration, 266 nmoles of ADP 
were put into the same cell. The temperature of the 
incubation medium was 26 °C. Oxygen consumption 
by mitochondria was measured by means of the cove-
red combined platinum electrode of Clark’s electrode 
type. Protein was defined by method of Lowry. All 
reagents were from “SIGMA”. For statistical analysis 
Student’s t-criterion was used.
RESULTS AND DISCUSSION
As it was mentioned above, for antitumor activity 
study of FM nanoparticles and doxorubicin against 
Ehrlich ascitic carcinoma cells, following groups were 
formed: control (N1); single intraperitoneal doxorubi-
cin injection (N2; Dox); single intraperitoneal FM nano-
particles administration (N3; FM); FM administration 
(i/p; 3 mg/kg) and Dox administration (i/p; 3 mg/kg) 
an hour later (N4; FM + Dox); Dox administration 
and FM administration an hour later (N5; Dox + FM). 
Injections were performed 7 days after intraperito-
neal tumor transplantation. In the last two groups the 
sequence of intraperitoneal administration of studied 
agents was specially changed as it wasn’t known which 
combination is optimal. In the literature the doses 
for administration relative to iron (FM nanoparticles) 
were equal to 0.8–8 mg/kg [17–19]. But we stopped 
at an apparently average dose of 3 mg/kg. The results 
of combined therapy experiments (Fig. 2) showed that 
the FM nanoparticles stabilized by polydextrane-70, 
48 h after the therapeutic injection did not show prolife-
ration stimulation of Ehrlich ascitic carcinoma cells. 
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Fig. 2. Percentage of dead cells in ascitic fluid 48 h after ad-
ministration (n = 10)
At the same time the data that we obtained during 
dead cells number counting in the ascitic fluid of animals 
(see Fig. 2) indicated the increase of the dead cells in all 
experimental groups compared with the control group. 
Particularly FM nanoparticles and doxorubicin itself in-
creased the index by 22% and 31%, respectively. It could 
be that if FM nanoparticles of such size would be concen-
trated in solid tumors with the help of magnetic field, then 
antitumor therapy could become more effective. 
FM nanoparticles administration before doxorubicin 
injection increased the number of dead cells in ascitic 
fluid by 6% compared to doxorubicin alone. Moreover, 
FM administration after the Dox injection increased this 
number by 14%. The percentage of dead cells in ascitic 
fluid of animals from groups 1–5 was equal to 7%, 38%, 
29%, 44% and 52%, respectively (see Fig. 2). 
It should be noted that the similar data were pre-
sented in [13]. However authors used entirely different 
magnet-controlled nanoparticles. The cytotoxic effect 
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of Dox, FM and their combination was less expressed 
in 24 and 72 h after administration of agents than 
in 48 h. Thereby, we studied apoptosis induction in tu-
mor cells. The number of apoptotic cells in the fifth 
group (Dox + FM) 48 h after agents administration 
reached 65% (Table 2), while the number of tumor 
apoptotic cells in animals treated with doxorubicin 
alone was 45%.
Table 2. Number of cells in apoptosis (in vivo) 
Group Number of cells in apoptosis, %
1 (Control) 0–1
2 (Dox) 45
3 (FM) 3–5
4 (FM + Dox) 58
5 (Dox + FM) 65
Since doxorubicin is a phase-specific preparation 
and the biggest sensitivity to it is observed in S-phase 
[20], we studied influence of doxorubicin, FM nano-
particles and their combinations on the cell distribution 
by cell cycle phases. In groups where animals were 
administrated with Dox (N2, N4 and N5) we observed 
significant decrease in number of cells in S-phase. 
In group 5 the cells number in G0 + G1-phase was 
increased (Fig. 3, Table 3).
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Fig. 3. The cell cycle analysis (in vivo)
Table 3. Distribution of Ehrlich ascitic carcinoma cells treated 
by FM nanoparticles and Dox by cell cycle phases (in vivo)
Cell cycle phases Number of cells, % (control group)
Number of cells, % 
(Dox + FM)
G0 + G1 25.55 41.79
S-phase 61.27 48.65 
G2 + M 13.18 9.56 
The results of cell cycle study of Ehrlich ascitic tu-
mor cells are presented in Fig. 4 and Fig. 5. Incubation 
of tumor cells with two agents for 48 h resulted in the 
decrease of cells number in S-phase and the increase 
of cells population in G0 + G1 phase. However, it should 
be mentioned that Dox concentration used during 
incubation was varied, but FM concentration was con-
stant. In this case though the picture of cells distribu-
tion in cell cycle has changed but was not proportional 
to the Dox concentration. It apparently indicates that 
the cell cycle is mainly influenced by FM.
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Fig. 4. The cell cycle of Ehrlich carcinoma cells 48 h after incu-
bation with Dox and FM (in vitro). a — control; b — 1 μM Dox + 
FM; c — 10 μM Dox + FM; d — 100 μM Dox + FM
Taking into account that many complexes of mito-
chondria respiratory chain contain iron [15], we have 
investigated the influence of ferromagnetic nano-
particles on tumor cell oxygen consumption and 
mitochondria oxidative phosphorylation. Ferromag-
netic concentration (Fe content, μg/ml) in experiments 
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in vitro was choiced according to isoeffectiveness 
of cytotoxic preparation effect in vivo. It was found 
that 1.45 μg Fe/ml, 7.25 μg Fe/ml and 14.5 μg Fe/ml 
resulted in the decrease of oxygen consumption rate 
by tumor cells (by 6%, 51%, 68%, respectively; Fig. 6). 
The 7.25 μg Fe/ml resulted in the decrease of mito-
chondria oxygen consumption in state 2 (V2; P < 0.05). 
But mitochondria oxygen consumption rate in phos-
phorylation state (V3; at ATP synthesis) decreased 
essentially: at 1.45 μg Fe/ml — by 25% (P < 0.01), 
at 7.25 μg Fe/ml — by 37% (P < 0.001; Table 4). In turn, 
it resulted in the decrease of respiratory control and 
ATP production. But decoupling of mitochondria oxida-
tive phosphorylation was not observed. 
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Fig. 5. The distribution of Ehrlich carcinoma cells by cell cycle 
phases 48 h after incubation with Dox and FM (in vitro)
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Fig. 6. The rate of oxygen consumption by Ehrlich carcinoma 
cells incubated with FM nanoparticles 
*Significantly different from control (n = 7).
Table 4. The respiration of mitochondria from tumor cells treated 
by FM nanoparticles (M ± m; n = 7)
Fe concen-
tration V2 V3 V4 RCI ADP/O 
0 (control) 23.2 ± 0.8 105.6 ± 2.3 23.2 ± 0.8 4.6 ± 0.2 1.9 ± 0.01
1.45 µg Fe/ml 21.0 ± 0.6 79.0 ± 1.6* 21.0 ± 0.6 3.8 ± 0.1* 1.84 ± 0.02*
7.25 µg Fe/ml 20.6 ± 0.7 66.4 ± 1.5* 20.6 ± 0.7 3.2 ± 0.1* 1.83 ± 0.02*
*Significantly different from control; V2, V3, V4 — [(nanoatoms O2/min) / 
mg protein]. V2 — the rate of oxygen consumption by mitochondria in the pre-
sence of substrate for oxidation (succinate). V3 — the rate of oxygen consump-
tion during phosphorylation of ADP added into a polarographic cell. V4 — the 
rate of oxygen consumption after ADP transformation into ATP. RCI — the re-
spiratory control index. ADP/O — the index showing the number of ATP mole-
cules synthesized per 1 absorbed O2 atom.
Thus, the FM nanoparticles (20–40 nm) increase 
the cytotoxic effect of Dox against Ehrlich ascіtic car-
cinoma. The largest number of apoptotic cells was 
observed in group of animals in which doxorubicin 
was administered before FM nanoparticles. Moreover, 
the FM nanoparticles at concentration 1.45 μg Fe/ml 
and, particularly, 7.25 μg Fe/ml decreased the mi-
tochondria oxygen consumption in phosphorylation 
state that may negatively influence their living capabi-
lity. Obtained results point out the perspective of use 
of FM nanoparticles to increase the cytotoixc effect 
of antitumor drugs. However, future research should 
be also devoted to the study of FM nanoparticles toxic 
effects on organism.
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